Present and Future of Thyroid Ablation FEBRUARY 6 – 7, 2025.

Resumen

Minimally Invasive Thyroid Treatments (MITT) are reaching an increasingly important role in the management of patients with benign and malignant thyroid diseases. The MITT group has been founded in 2018 to promote multidisciplinary partnership among physicians with different expertise who share the interest in MITT and to improve the clinical, diagnostic, and therapeutic management of benign and malignant thyroid and parathyroid glands diseases.